BESIVANCE

This brand name is authorized in United States. It is also authorized in Brazil, Canada, Singapore, Turkey.

Active ingredients

The drug BESIVANCE contains one active pharmaceutical ingredient (API):

1	Besifloxacin UNII BFE2NBZ7NX - BESIFLOXACIN
	Besifloxacin is a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis.
	Read more about Besifloxacin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
BESIVANCE Ophthalmic suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AE08		S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones
Discover more medicines within S01AE08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	503101301134315
CA	Health Products and Food Branch	02336847
SG	Health Sciences Authority	14021P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699856712278
US	FDA, National Drug Code	24208-446